SCHEMBL7256690

SCHEMBL7256690

CCc1cc(OC)cc2c1c(=O)c(-c1ccc(OC)cc1)cn2C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 4/20 0.51
▸ ALDH1A1 P00352 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ NFKB1 P19838 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ NFKB2 Q00653 2/20 0.41
▸ RELA Q04206 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ NUAK1 O60285 1/20 0.41
▸ SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257625 0.84 ALDH1A1 (0.55) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7256796 0.83 EGFR (0.71) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7257567 0.83 EGFR (0.52) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7261257 0.83 EGFR (0.47) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL2070866 0.82 EGFR (0.57) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7256786 0.81 EGFR (0.46) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7256693 0.81 EGFR (0.50) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7260740 0.78 EGFR (0.47) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7261303 0.77 EGFR (0.47) EGFRALDH1A1NPC1RAB9AKDM4E
SCHEMBL7262238 0.77 EGFR (0.44) EGFRALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645983-B1 Heterocyclic imines such as 3-(4-methoxyphenyl)-1,4-dihydro-4 -quinolinone, used as anticarcinogenic agents having cytolysis efficiency; side effect reduction LABORATOIRE L. LAFON (FR) 2003-11-11 — — US disclosed
EP-1202971-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES LABORATOIRE L. LAFON (FR) 2002-05-08 — — EP disclosed
WO-2002022074-A2 USE OF 2- AND 4- QUINOLONES FOR INHIBITING INTIMAL NEO-PROLIFERATION LABORATOIRE L. LAFON (FR) 2002-03-21 — — WO disclosed
WO-2001012607-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES FOR TREATING CANCERS LABORATOIRE L. LAFON (FR) 2001-02-22 — — WO disclosed
Send feedback